KMT2B rare missense variants in generalized dystonia

ABSTRACT Background: Recently a novel syndrome of childhood‐onset generalized dystonia originating from mutations in lysine‐specific methyltransferase 2B (KMT2B) has been reported. Methods: We sequenced the exomes of 4 generalized dystonia‐affected probands recruited from a Prague movement disorders...

Full description

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 32; no. 7; pp. 1087 - 1091
Main Authors Zech, Michael, Jech, Robert, Havránková, Petra, Fečíková, Anna, Berutti, Riccardo, Urgošík, Dušan, Kemlink, David, Strom, Tim M., Roth, Jan, Růžička, Evžen, Winkelmann, Juliane
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.07.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ABSTRACT Background: Recently a novel syndrome of childhood‐onset generalized dystonia originating from mutations in lysine‐specific methyltransferase 2B (KMT2B) has been reported. Methods: We sequenced the exomes of 4 generalized dystonia‐affected probands recruited from a Prague movement disorders center (Czech Republic). Bioinformatics analyses were conducted to select candidate causal variants in described dystonia‐mutated genes. After cosegregation testing, checklists from the American College of Medical Genetics and Genomics were adopted to judge variant pathogenicity. Results: Three novel, predicted protein‐damaging missense variants in KMT2B were identified (p.Glu1234Lys, p.Ala1541Val, p.Arg1779Gln). Meeting pathogenicity criteria, p.Glu1234Lys was absent from population‐based controls, situated in a key protein domain, and had occurred de novo. The associated phenotype comprised adolescence‐onset generalized isolated dystonia with prominent speech impairment. Although linked to a similar clinical expression, p.Ala1541Val and p.Arg1779Gln remained of uncertain significance. Conclusions: Rare missense variation in KMT2B represents an additional cause of generalized dystonia. Application of sequence interpretation standards is required before assigning pathogenicity to a KMT2B missense variant. © 2017 International Parkinson and Movement Disorder Society
Bibliography:Nothing to report.
Relevant conflicts of interests/financial disclosures
Funding agencies
This study was funded by the Czech Science Foundation (GACR16‐13323S) as well as in‐house institutional funding from Technische Universität München, Munich, Germany; Helmholtz Zentrum München, Munich, Germany; and Charles University, Prague, Czech Republic (PRVOUK P26/LF1/4).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0885-3185
1531-8257
DOI:10.1002/mds.27026